Startups
PAhR Therapeutics
Develops therapies for pulmonary arterial hypertension, a disease involving high blood pressure in the arteries connecting the heart and lungs. Its approach builds on vascular-physiology research from Japan’s National Cerebral and Cardiovascular Center. The clinical-stage company was incubated at RA Capital’s Raven incubator.